José Antônio Martins

José Antônio Martins

Auto-generated profile, based on publicly available information

José Antônio Martins

Centro ALGORTIMI/LASI, Universidade do Minho, Braga, Portugal

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2005 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MFMatheus P. Freitas
Matheus P. Freitas
SBSteven D. Brown
Steven D. Brown
JMJosé A. Martins
José A. Martins

1 September 2005 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MFMatheus P. Freitas
Matheus P. Freitas
ASAndréia Sabadin
Andréia Sabadin
LSLeandro M. Silva
Leandro M. Silva
FGFábio M. Giannotti
Fábio M. Giannotti
DCDébora A. Do Couto
Débora A. Do Couto
JMJosé A. Martins
José A. Martins

28 August 2023 in IEEE Transactions on Very Large Scale Integration (VLSI) Systems
Verified
Journal Article
Open access
BSBruno Sá
Bruno Sá
LVLuca Valente
Luca Valente
JMJosé Martins
José Martins
DRDavide Rossi
Davide Rossi
LBLuca Benini
Luca Benini
SPSandro Pinto
Sandro Pinto
Virtualization is a key technology used in a wide range of applications, from cloud computing to embedded systems. Over the last few years, mainstream computer architectures were extended with hardware virtualization support, giving rise to a set of virtualization technologies (e.g., Intel VT and Arm VE) that are now proliferating in modern processors and systems on chip (SoCs). In this article, we describe our work on hardware virtualization support in the RISC-V CVA6 core. Our contribution is multifold and encompasses architecture, microarchitecture, and design space exploration (DSE). In particular, we highlight the design of a set of microarchitectural enhancements [i.e., G-stage translation lookaside buffer (GTLB) and second-level TLB (L2 TLB)] to alleviate the virtualization performance overhead. We also perform a DSE and accompanying postlayout simulations (based on 22-nm FDX technology) to assess performance, power, and area (PPA). Furthermore, we map design variants on a field-programmable gate array (FPGA) platform (Genesys 2) to assess the functional performance–area tradeoff. Based on the DSE, we select an optimal design point for the CVA6 with hardware virtualization support. For this optimal hardware configuration, we collected functional performance results by running the MiBench benchmark on Linux atop Bao hypervisor for a single-core configuration. We observed a performance speedup of up to 16% (approximately 12.5% on average) compared with virtualization-aware nonoptimized design at the minimal cost of 0.78% in area and 0.33% in power. Finally, all works described in this article are publicly available and open-sourced for the community to further evaluate additional design configurations and software stacks.

1 January 2006 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
SBSabrina C. Baratieri
Sabrina C. Baratieri
JBJuliana M. Barbosa
Juliana M. Barbosa
MFMatheus P. Freitas
Matheus P. Freitas
JMJosé A. Martins
José A. Martins

1 January 2010 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Open access
PDF file
WRWerickson F. C. Rocha
Werickson F. C. Rocha
ARAndré Luis Rosa
André Luis Rosa
JMJosé Antônio Martins
José Antônio Martins
RPRonei Poppi
Ronei Poppi
The determination of nimesulide in pharmaceutical formulation in the range of 10.38 to 39.47% m/m using near infrared spectroscopy and multivariate calibration based on partial least squares (PLS) and net analyte signal (NAS) was studied and validated by establishing its figures of merit. Suitable results were obtained, with limit of detection of 0.61%, limit quantification of 2.03%, accuracy estimated as root mean square error of prediction (RMSEP) of 1.05%, mean selectivity of 0.006, sensitivity of 0.004%, inverse analytical sensitivity of (0.20%)-1 and signal-to-noise ratio of 181. In addition, it was obtained relative errors lower than 10% that are acceptable values for quality control of this drug. These results indicate that the proposed method can be used in pharmaceutical industries as an alternative to standard analytical procedures.

1 February 2010 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
KSKely Ferreira de Souza
Kely Ferreira de Souza
JMJosé A. Martins
José A. Martins
FPFrancisco B.T. Pessine
Francisco B.T. Pessine
RCRogério Custodio
Rogério Custodio